Byrne, Jude ×
2 results
  1. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

    Grebely, Jason, Dalgard, Olav, Conway, Brian, Cunningham, Evan B., Bruggmann, Philip, Hajarizadeh, Behzad, Amin, Janaki, Bruneau, Julie, Hellard, Margaret, Litwin, Alain H., Marks, Phillippa, Quiene, Sophie, Siriragavan, Sharmila, Applegate, Tanya L., Swan, Tracy, Byrne, Jude, Lacalamita, Melanie, Dunlop, Adrian, Matthews, Gail V., Powis, Jeff, Shaw, David, Thurnheer, Maria Christine, Weltmann, Martin, Kronborg, Ian, Cooper, Curtis, Feld, Jordan J., Fraser, Chris, Dillon, John F., Read, Phillip, Gane, Edward, Dore, Gregory J. ()
  2. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.

    Grebely, Jason, Bruneau, Julie, Lazarus, Jeffrey, Dalgard, Olav, Bruggmann, Philip, Treloar, Carla, Hickman, Matthew, Hellard, Margaret, Roberts, Teri, Crooks, Levinia, Midgard, Håvard, Larney, Sarah, Degenhardt, Louisa, Alho, Hannu, Byrne, Jude, Dillon, John F, Feld, Jordan J, Foster, Graham, Goldberg, David E, Lloyd, Andrew R, Reimer, Jens, Robaeys, Geert, Torrens, Marta, Wright, Nat, Maremmani, Icro, Norton, Brianna L, Litwin, Alain H, Dore, Gregory J ()